Overview

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This double-blind, randomized study will compare the efficacy and acceptability of mifepristone 200mg followed in 36-48 hours by 400mcg or 800mcg of buccal misoprostol (i.e., in the cheeks) for termination of pregnancy in women up to 63 days LMP.
Phase:
N/A
Details
Lead Sponsor:
Gynuity Health Projects
Treatments:
Mifepristone
Misoprostol